297 related articles for article (PubMed ID: 30036136)
1. Antibacterial Activity of DC-159a Against Salmonella Typhimurium.
Koide K; Kongsoi S; Ouchi Y; Yamaguchi T; Nakajima C; Suzuki Y
Microb Drug Resist; 2019; 25(1):14-22. PubMed ID: 30036136
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of quinolone-resistant mechanisms in a lab-selected Salmonella enterica typhimurium mutant.
Gu Y; Xu X; Lin L; Ren X; Cui X; Hou X; Cui S
Microb Drug Resist; 2013 Feb; 19(1):15-20. PubMed ID: 23013383
[TBL] [Abstract][Full Text] [Related]
3. Amino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimurium.
Kongsoi S; Changkwanyeun R; Yokoyama K; Nakajima C; Changkaew K; Suthienkul O; Suzuki Y
Drug Test Anal; 2016 Oct; 8(10):1065-1070. PubMed ID: 26514939
[TBL] [Abstract][Full Text] [Related]
4. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Levy DD; Sharma B; Cebula TA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
[TBL] [Abstract][Full Text] [Related]
6. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.
Marimón JM; Gomáriz M; Zigorraga C; Cilla G; Pérez-Trallero E
Antimicrob Agents Chemother; 2004 Oct; 48(10):3789-93. PubMed ID: 15388435
[TBL] [Abstract][Full Text] [Related]
7. WQ-3810 exerts high inhibitory effect on quinolone-resistant DNA gyrase of
Koide K; Kongsoi S; Nakajima C; Suzuki Y
Biosci Biotechnol Biochem; 2019 Dec; 83(12):2249-2256. PubMed ID: 31382821
[TBL] [Abstract][Full Text] [Related]
8. Quinolone Resistance Mechanisms Among Salmonella enterica in Malaysia.
Thong KL; Ngoi ST; Chai LC; Teh CS
Microb Drug Resist; 2016 Jun; 22(4):259-72. PubMed ID: 26683630
[TBL] [Abstract][Full Text] [Related]
9. Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica.
Randall LP; Cooles SW; Piddock LJ; Woodward MJ
J Antimicrob Chemother; 2004 Sep; 54(3):688-91. PubMed ID: 15243029
[TBL] [Abstract][Full Text] [Related]
10. The role of ATP pools in persister cell formation in (fluoro)quinolone-susceptible and -resistant strains of Salmonella enterica ser. Typhimurium.
Braetz S; Schwerk P; Thompson A; Tedin K; Fulde M
Vet Microbiol; 2017 Oct; 210():116-123. PubMed ID: 29103680
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Development of Ciprofloxacin Resistance of Salmonella enterica Serovars Typhimurium, Enteritidis, and Indiana Isolates from Food Animals.
Zhang WH; Zhang CZ; Liu ZJ; Gu XX; Li W; Yang L; Liu YH; Zeng ZL; Jiang HX
Microb Drug Resist; 2017 Sep; 23(6):687-694. PubMed ID: 28085562
[TBL] [Abstract][Full Text] [Related]
12. Presence of plasmid-mediated quinolone resistance determinants and mutations in gyrase and topoisomerase in Salmonella enterica isolates with resistance and reduced susceptibility to ciprofloxacin.
Casas MR; Camargo CH; Soares FB; da Silveira WD; Fernandes SA
Diagn Microbiol Infect Dis; 2016 May; 85(1):85-9. PubMed ID: 26971183
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the plasmid-encoded quinolone resistance protein QnrB19 with Salmonella Typhimurium DNA gyrase.
Pachanon R; Koide K; Kongsoi S; Nakajima C; Kapalamula TF; Suthienkul O; Suzuki Y
J Infect Chemother; 2020 Nov; 26(11):1139-1145. PubMed ID: 32669211
[TBL] [Abstract][Full Text] [Related]
14. Amino Acid Substitution Ser83Ile in GyrA of DNA Gyrases Confers High-Level Quinolone Resistance to Nontyphoidal
Koide K; San LL; Pachanon R; Park JH; Ouchi Y; Kongsoi S; Utrarachkij F; Nakajima C; Suzuki Y
Microb Drug Resist; 2021 Oct; 27(10):1397-1404. PubMed ID: 33877914
[No Abstract] [Full Text] [Related]
15. Isolation and characterization of small qnrS1-carrying plasmids from imported seafood isolates of Salmonella enterica that are highly similar to plasmids of clinical isolates.
Akiyama T; Khan AA
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):429-32. PubMed ID: 22151215
[TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.
Choi SH; Woo JH; Lee JE; Park SJ; Choo EJ; Kwak YG; Kim MN; Choi MS; Lee NY; Lee BK; Kim NJ; Jeong JY; Ryu J; Kim YS
J Antimicrob Chemother; 2005 Dec; 56(6):1111-4. PubMed ID: 16244086
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Salmonella Typhimurium DNA gyrase as a target of quinolones.
Kongsoi S; Yokoyama K; Suprasert A; Utrarachkij F; Nakajima C; Suthienkul O; Suzuki Y
Drug Test Anal; 2015 Aug; 7(8):714-20. PubMed ID: 25381884
[TBL] [Abstract][Full Text] [Related]
18. Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005.
Akiba M; Nakaoka Y; Kida M; Ishioka Y; Sameshima T; Yoshii N; Nakazawa M; Uchida I; Terakado N
J Antimicrob Chemother; 2007 Dec; 60(6):1235-42. PubMed ID: 17956907
[TBL] [Abstract][Full Text] [Related]
19. Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
Delsol AA; Woodward MJ; Roe JM
J Antimicrob Chemother; 2004 Feb; 53(2):396-8. PubMed ID: 14711838
[TBL] [Abstract][Full Text] [Related]
20. Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica.
Fàbrega A; Soto SM; Ballesté-Delpierre C; Fernández-Orth D; Jiménez de Anta MT; Vila J
J Antimicrob Chemother; 2014 Jul; 69(7):1815-24. PubMed ID: 24706735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
